Oncolytic Virus Therapy

Oncolytic virus therapy, often known as virus therapy, employs modified viruses created in a lab to kill cancer cells. The virus is injected into the tumor in a genetically altered form. The virus replicates itself when it gets inside the cancer cells. The cancer cells consequently burst and pass away. When a cell dies, it releases proteins that cause your immune system to begin attacking any cancer cells in your body that have the same proteins. Healthy cells are not invaded by the virus. It is authorized to use this oncolytic viral therapy to treat advanced melanoma that cannot be surgically removed. People who cannot or do not want to receive any other suggested treatment typically use it treatments. The herpes simplex virus, which causes cold sores, has undergone modification to become T-VEC.

    Related Conference of Oncolytic Virus Therapy

    November 26-27, 2024

    38th International Conference on Immunology

    Madrid, Spain
    December 12-13, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland
    June 16-17, 2025

    19th International Conference on European Immunology

    Frankfurt, Germany

    Oncolytic Virus Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in